Article Details

Deals surge, returns slip: takeaways from a record half for biotech IPOs

Retrieved on: 2021-06-30 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Deals surge, returns slip: takeaways from a record half for biotech IPOs. View article details on hiswai:

Excerpt

There were 71 biotech offerings of at least $50 million, compared to 38 and 44, respectively, in the two prior years, according to Biopharma Dive's ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo